- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05675618
Return to Golf After Orthopaedic Surgery
January 11, 2024 updated by: Hospital for Special Surgery, New York
Golfing After Orthopaedic Surgery: a Longitudinal Follow-up (GOLF) Project
The GOLF study is a multicenter, prospective study with the goal to investigate golfers' return to the sport following hip, knee or shoulder arthroplasty.
The prevalence of return to golf, by level of returning to golf will be assessed at 6 weeks, 3 months, 6 months, and 12 months postoperatively.
Patients who are active golfers undergoing joint replacement will be identified from outpatient clinics and pre-assessment clinics and given information about the study at least two weeks prior to surgery.
Participants in this study must have a desire to return to golf after surgery.
Previous studies have only been able to report the return to golf after arthroplasty retrospectively; the prospective nature of this study will allow for a greater understanding of this process.
Study Overview
Status
Recruiting
Study Type
Observational
Enrollment (Estimated)
432
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Andrew Creighton, DO
- Phone Number: 646-344-4340
- Email: creightona@hss.edu
Study Contact Backup
- Name: Jennifer Cheng
- Email: chengj@hss.edu
Study Locations
-
-
-
Edinburgh, United Kingdom
- Recruiting
- Royal Infirmary Of Edinburgh
-
Contact:
- Patrick Robinson
-
-
-
-
New York
-
New York, New York, United States, 10021
- Recruiting
- Hospital for Special Surgery
-
Contact:
- Andrew Creighton
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Adult patients undergoing joint replacement surgery who are self-reported golfers and have a desire to return to golf postoperatively
Description
Inclusion Criteria:
- Age 18+ years
- A self-reported golfer
- Able to consent to treatment
- Indicated for one of the following surgical procedures: total hip arthroplasty, hip resurfacing, revision hip arthroplasty, total knee arthroplasty, unicompartmental knee arthroplasty, revision knee arthroplasty, total shoulder arthroplasty, reverse shoulder arthroplasty, shoulder resurfacing arthroplasty, revision shoulder arthroplasty
Exclusion Criteria:
- Inability to complete follow-up questionnaires
- Declining operative management
- No desire to return to golf postoperatively
- Medical problem that affects the patient's ability to play golf (e.g., angina, shortness of breath, etc.)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of return to golf following joint arthroplasty
Time Frame: Up to 1 year postoperatively
|
Patients will be asked if they have returned to golf (putting, chipping, 9 holes, 18 holes, etc) following joint arthroplasty.
|
Up to 1 year postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Golf awareness after arthroplasty score
Time Frame: Up to 1 year postoperatively
|
This questionnaire assesses awareness of the joint replacement while playing golf and engaging in specific golf activities.
A higher score represents more awareness, whereas a lower score represents less awareness.
|
Up to 1 year postoperatively
|
Hip Disability and Osteoarthritis Outcome Score for Joint Replacement (HOOS JR)
Time Frame: Up to 1 year postoperatively
|
The HOOS JR measures overall hip health on a scale of 0-100, where 0 represents total hip disability and 100 represents perfect hip health.
This will be administered specifically to patients undergoing hip arthroplasty.
|
Up to 1 year postoperatively
|
Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS JR)
Time Frame: Up to 1 year postoperatively
|
The KOOS JR measures overall knee health on a scale of 0-100, where 0 represents total knee disability and 100 represents perfect knee health.
This will be administered specifically to patients who undergo knee arthroplasty.
|
Up to 1 year postoperatively
|
American Shoulder and Elbow Surgeons Shoulder Score (ASES)
Time Frame: Up to 1 year postoperatively
|
The ASES measures shoulder function on a scale of 0-100, where 0 represents worse function and 100 represents best function.
This will be administered specifically to patients who undergo shoulder arthroplasty.
|
Up to 1 year postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 9, 2023
Primary Completion (Estimated)
January 1, 2025
Study Completion (Estimated)
December 1, 2025
Study Registration Dates
First Submitted
December 28, 2022
First Submitted That Met QC Criteria
December 28, 2022
First Posted (Actual)
January 9, 2023
Study Record Updates
Last Update Posted (Actual)
January 12, 2024
Last Update Submitted That Met QC Criteria
January 11, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-0437
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
Tianjin XinChen-Techfields Pharma Co., LTD.Completed
-
Eun Jung KimMinistry of Health & Welfare, Korea; Semyung UniversityUnknownOsteoarthritis KneeKorea, Republic of
-
Thammasat UniversityCompletedPrimary Knee OsteoarthritisThailand
-
Galderma R&DCompletedUnilateral Knee OsteoarthritisUnited Kingdom